INGN Inogen, Inc.
Healthcare$6.40-0.16%ClosedMarket Cap: $173.3M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.96
P/S
0.49
EV/EBITDA
-18.59
DCF Value
$-6.53
FCF Yield
-5.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
48.7%
Operating Margin
-8.8%
Net Margin
-7.1%
ROE
-12.9%
ROA
-8.7%
ROIC
-13.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $85.1M | 49.1% | $-8.4M | $-8.3M | $— | — |
| Q4 null | $81.7M | 50.4% | $-9.3M | $-7.1M | $— | — |
| FY null | $348.7M | 47.6% | $-30.2M | $-22.7M | $— | — |
| Q3 null | $92.4M | 50.8% | $-7.1M | $-5.3M | $— | — |
| Q2 null | $92.3M | 44.8% | $-6.1M | $-4.2M | $— | — |
| Q1 null | $82.3M | 44.2% | $-7.7M | $-6.2M | $— | — |
| Q4 null | $80.1M | 45.3% | $-11.4M | $-9.8M | $— | — |
| FY null | $335.7M | 46.1% | $-42.5M | $-35.9M | $— | — |
| Q3 null | $88.8M | 46.5% | $-7.8M | $-6.0M | $— | — |
| Q2 null | $88.8M | 48.1% | $-7.1M | $-5.6M | $— | — |
| Q1 null | $78.0M | 44.1% | $-16.3M | $-14.6M | $— | — |
| Q4 2023 | $75.9M | 37.1% | $-29.0M | $-26.6M | $-1.14 | — |